At Kallyope, we are leveraging unique insights into neural signaling pathways and developing innovative medicines for the treatment of migraine. Our late-stage pipeline focuses on delivering an effective, easy to use, first-in-class medication. Kallyope was founded by world-leading neuroscientists whose groundbreaking research into previously unexplored neural networks is now being carried forward by a team of experienced drug developers. Elismetrep, our lead asset being developed for the acute treatment of migraine, is in Phase 3.
Looking for a particular Kallyope employee's phone or email?
Kallyope Questions
The Kallyope annual revenue was $15.1 million in 2026.
Jay Galeota is the President and Chief Executive Officer of Kallyope.
49 people are employed at Kallyope.
Kallyope is based in New York, New York.
The NAICS codes for Kallyope are [54, 54171, 5417, 541713, 541].
The SIC codes for Kallyope are [873, 87].
Top Kallyope Employees
-
Jay Galeota
President and Chief Executive Officer at Kallyope
Metuchen, NJ, US25 -
Brett Lauring
Chief Medical Officer at Kallyope
New York, NY, US45 -
Michael Luzung
Vice President at Kallyope
New York, NY, US21 -
Maury Spadoto
Vice President - FP and A and HR at Kallyope
New York, NY, US22 -
23
-
Shirly Pinto
Chief Scientific Officer at Kallyope
United States22 -
Robert Saklatvala
Vice President at Kallyope
Boston, MA, US22 -
Jiajun Liu
VP, Head of Biometrics at Kallyope
Boston, MA, US24 -
Nancy Thornberry
Member, Board of Directors at Kallyope
New York, NY, US25+
Related Companies
